Grant: Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
McGill University
$50,000.00
The role of mTOR pathway in age-associated memory decline.
FY 2010-11
Summary
Recent advances in health care have enabled significant increases in lifespan. Normal aging is accompanied by the increased incidence of age-related diseases. Age-associated cognitive decline is a devastating condition that affects much of the elderly population to various degrees. Caloric restriction has been shown to prolong lifespan in different species. Interestingly, caloric restriction also shows the benefit of improved memory in aged rodents, primates, and humans. Caloric restriction has been suggested to mediate its effects on lifespan in part through inhibition of the mTOR pathway. The mTOR pathway acts as a central sensor of the cell's energy and nutrient status and coordinates cell activities towards maintaining equilibrium. Indeed, mTOR inhibition by the drug rapamycin prolongs lifespan in mice. However, the effect of mTOR pathway inhibition on age-associated memory decline is unknown. We propose to mimic the beneficial effect of caloric restriction on age-associated memory impairment by inhibiting the mTOR pathway using pharmacological and genetic approaches.
Department
Program
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
228785
Name
Sonenberg Nahum
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
The role of mTOR pathway in age-associated memory decline.
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Keyworddelim
Age-Associated Memory Decline; Aging; Caloric Restriction; Metformin; Mtor Pathway; Rapamycin
Abstract
Recent advances in health care have enabled significant increases in lifespan. Normal aging is accompanied by the increased incidence of age-related diseases. Age-associated cognitive decline is a devastating condition that affects much of the elderly population to various degrees. Caloric restriction has been shown to prolong lifespan in different species. Interestingly, caloric restriction also shows the benefit of improved memory in aged rodents, primates, and humans. Caloric restriction has been suggested to mediate its effects on lifespan in part through inhibition of the mTOR pathway. The mTOR pathway acts as a central sensor of the cell's energy and nutrient status and coordinates cell activities towards maintaining equilibrium. Indeed, mTOR inhibition by the drug rapamycin prolongs lifespan in mice. However, the effect of mTOR pathway inhibition on age-associated memory decline is unknown. We propose to mimic the beneficial effect of caloric restriction on age-associated memory impairment by inhibiting the mTOR pathway using pharmacological and genetic approaches.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sonenberg, Nahum
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Aging~ $50,000~ $0~